The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.
breast cancer
kellyhiggison
CSN Member Posts: 1
Comments
-
My onc told me that the Her2
My onc told me that the Her2 gene does help indicate the aggresivness of the cancer.
I am also triple +. I had a lumpectmy in Sep 09, finished chemo in Feb, finished rads in July and will have my last Herceptin treatment in Nov. Glad you caught your bc early, indicated by the stage 1. Mine was stage 2a because I had a microscopic amount of cancer cells in one lymph node.
hugs
Donna -
Welcome, Kelly
I'm sorry you happened to post on a day that our board was getting spammed -- the ACS administrator should be able to get things back to normal on Monday morning.
I'm not HER2 positive, but we have a lot of women here on this board who are. If I may make a suggestion -- why don't you make another post, with the subject line something like "Calling Other HER2 Positive Ladies," or something like that? That would make it more likely that you would hear from those here who can help you with your questions.
Traci -
Being triple negative is
Being triple negative is worse from what I've read as there are no drugs that can be used against it. Herceptin is used with HER2+ and there are several meds/drugs used with ER+. Personally - I'm HER2- so no Herceptrin for me but I'm ER+ so I'll be on Femara for at least another 4 years and quite probably for the rest of my life as I'm IBC (one of the more aggressive and rarer types). Certainly the sub-type (ER/PR/HER2)is important, but the type (IBC, IDC, LCIS, DCIS, etc.) is important. All do not react/respond the same nor have the same prognosis or treatment protocol.
Research, research, research, ask questions, ask questions and ask more questions. You are your best advocate but be armed with knowledge.
There is no "One size fits all" in this battle no matter what the 'general' DX is - we are each so unique and our bodies handle the assault on them in their own way.
Susan
Discussion Boards
- All Discussion Boards
- 7 Cancer Survivors Network Information
- 6 Welcome to CSN
- 1 CSN Update
- 122.7K Cancer specific
- 2.8K Anal Cancer
- 457 Bladder Cancer
- 311 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 410 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 682 Leukemia
- 805 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 243 Multiple Myeloma
- 7.2K Ovarian Cancer
- 71 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.7K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 745 Skin Cancer
- 663 Stomach Cancer
- 194 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.5K Lifestyle Discussion Boards


